Resultados de búsqueda - Rolf A. Stahel
- Mostrando 1 - 20 Resultados de 74
- Ir a la Siguiente Página
-
1
-
2
PD-1 blockade in advanced NSCLC: A focus on pembrolizumab por Solange Peters, Keith M. Kerr, Rolf A. Stahel
Publicado 2017Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin por Larisa Belyanskaya, Thomas M. Marti, Sally Hopkins-Donaldson, Stefanie Kurtz, Emanuela Felley‐Bosco, Rolf A. Stahel
Publicado 2007Artigo -
13
-
14
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1) por Ulf Petrausch, Petra Schuberth, Christian Hagedorn, Alex Soltermann, Sandra Tomaszek, Rolf A. Stahel, Walter Weder, Christoph Renner
Publicado 2012Artigo -
15
Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma☆ por Isabelle Opitz, Peter Kestenholz, Didier Lardinois, Michael Müller, Valentin Rousson, Didier Schneiter, Rolf A. Stahel, Walter Weder
Publicado 2006Artigo -
16
-
17
-
18
-
19
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation por Sally Hopkins‐Donaldson, Annemarie Ziegler, Stefanie Kurtz, Colette Bigosch, Daniela Kandioler, C Ludwig, Uwe Zangemeister‐Wittke, Rolf A. Stahel
Publicado 2003Artigo -
20
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Internal medicine
Oncology
Cancer
Biology
Lung cancer
Pathology
Chemotherapy
Biochemistry
Surgery
Mesothelioma
Cancer research
Gene
Cisplatin
Immunotherapy
Genetics
Immunology
Paleontology
Radiation therapy
Apoptosis
Breast cancer
Chemistry
Confidence interval
Molecular biology
Programmed cell death
Stage (stratigraphy)
Cell biology
Clinical trial
Medical physics
Pneumonectomy